Sanoh Biotech issued a volatility announcement. The company's controlling shareholder signed the 'Stock Transfer Agreement of Chengdu Sanoh Biotechnology Co., Ltd.' with Chuangfa Relief Fund on August 27, 2024. On September 30, 2024, a 'Supplementary Agreement to the Stock Transfer Agreement' was signed with Sichuan Development Securities Investment Fund Management Co., Ltd. After the signing of this supplementary agreement, Sano Investment plans to transfer its holding of 7,840,000 shares of the company's unlimited tradable shares (7.00% of the total share capital) to Chuangfa Investment through an agreement transfer at a price of 21.488 yuan per share, with a total transfer price of 0.168 billion yuan. The transfer of shares under this agreement needs to be confirmed for compliance by the Shanghai Stock Exchange before the share transfer procedures can be handled by the Shanghai Branch of China Securities Depository and Clearing Corporation Limited. There remains uncertainty as to whether this trade can be ultimately completed.